Products

Below is a list of the treatments we currently offer via our Innovative Medicines Division. 
Please note: Not all treatments are available in all countries.

Product Information

Indication: Myelofibrosis, Polycythemia vera Protein kinase inhibitors, Graft-versus-host disease (GvHD)

Active Ingredients - Ruxolitinib

Product Division - Novartis Pharmaceuticals